No Data
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix Insiders Sell US$577k Of Stock, Possibly Signalling Caution
Quite a few Ocular Therapeutix, Inc. (NASDAQ:OCUL) insiders sold their shares over the past year, which may be a cause for concern. When evaluating insider transactions, knowing whether insiders are
Ocular Therapeutix Price Target Maintained With a $15.00/Share by Piper Sandler
Ocular Therapeutix Price Target Maintained With a $15.00/Share by Piper Sandler
Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $15
Piper Sandler analyst Biren Amin maintains $Ocular Therapeutix(OCUL.US)$ with a buy rating, and maintains the target price at $15.According to TipRanks data, the analyst has a success rate of 40.7% an
Ocular Therapeutix Jumps as TD Cowen Upgrades to Buy and Hikes PT
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results.Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, be